German Study Finds Novel Chemotherapy Technique Extends Mesothelioma Survival, According to Surviving Mesothelioma

Share Article

Scientists say the key is confining chemotherapy drugs to the chest area, where they can have the most impact on the mesothelioma tumor.

Minimizing Mesothelioma Chemotherapy Side Effects

New Chemotherapy Technique for Mesothelioma

“ITP-F for patients with advanced pleural an effective and well-tolerated treatment...

Researchers in Burghausen, Germany have just released their findings on a new chemotherapy technique that maximizes the effectiveness of chemotherapy for pleural mesothelioma, while minimizing the damage to healthy tissue. Surviving Mesothelioma has the full story. Click here to read it now.

The study involved 28 patients with malignant pleural mesothelioma. Before administering chemotherapy, doctors blocked their aorta and inferior vena cava at the level of the diaphragm. The upper arms were blocked with pneumatic cuffs.

Each patient then received chemotherapy for 15 minutes, followed by chemofiltration to filter out most of the toxic drugs from their system. The technique is called isolated thoracic perfusion with chemofiltration (ITP-F).

“ITP-F for patients with advanced pleural mesothelioma, progressive after standard therapies, is an effective and well-tolerated treatment modality, offering comparably long survival data at a good quality of life,” writes lead investigator Karl Reinhard Aiger, MD.

“Standard chemotherapy is only marginally effective for patients with pleural mesothelioma and the side effects can be life-threatening,” says Alex Strauss, Managing Editor for Surviving Mesothelioma. “ITP-F potentially offers a safer and more effective way to treat advanced mesothelioma patients.”

To read more about the ITP-F technique and the results of the new study, see Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival, now available on the Surviving Mesothelioma website.

Aigner, KR, et al, “Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma”, June 19, 2017, OncoTargets and Therapy, eCollection 2017,

For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website